WellCell Holdings Co., Limited (2477) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 4.49M
• Price to Earnings (P/E): 541.6
• Beta (1Y): 0.06
• Revenue Growth: 5.58%
• EPS Growth: 3.93%
• Country: HK
• Employees: 115
• Sector: Communication Services
• Sector Strength: 97
• Industry: Telecommunications Services
• EPS (TTM): <0.01
• Shares Outstanding: 1,000,000,000
• 10 Day Avg. Volume: 2,724,320
• 30 Day Avg. Volume: 4,494,235
• PEG Ratio: 1.25K
• Price to Book (P/B): 29.64
• Price to Sales (P/S): 21.35
• P/FCF Ratio: -153.87
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$7.50
• Price Target Upside: -25.15% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 55 Neutral
• Price Target: HK$7.50 ▼(-25.15% Downside)

The overall stock score is primarily influenced by financial performance, which shows strong revenue growth but is offset by rising operational costs and declining cash flow. Technical analysis indicates a lack of strong momentum, and the high P/E ratio suggests overvaluation. The absence of earnings call data and corporate events means these factors do not influence the score.

WellCell Holdings Co., Limited Business Overview & Revenue Model

Company Description

WellCell Holdings Co., Limited (2477) is a health and wellness company that focuses on developing and distributing innovative health solutions and products aimed at enhancing the quality of life. Operating primarily in the healthcare sector, WellCell offers a range of products including nutritional supplements, wellness devices, and personalized health services. The company emphasizes research and development to drive innovation in its offerings, aligning with current health trends and consumer demands.

How the Company Makes Money

WellCell Holdings generates revenue through multiple channels, primarily through the sale of its health and wellness products, which include nutritional supplements and health devices. The company employs a direct-to-consumer sales model as well as partnerships with retail outlets and online platforms to expand its market reach. Additionally, WellCell may engage in collaborations with health organizations or research institutions, providing specialized services or products that contribute to its earnings. Marketing strategies focused on health trends and consumer education further enhance its sales, positioning the company within the growing health and wellness market.

WellCell Holdings Co., Limited Financial Statement Overview

Summary

WellCell Holdings shows strong revenue growth and stable profitability. However, rising operational costs and declining cash flow pose potential risks. The balance sheet remains strong with low leverage, but cash flow management needs improvement to sustain growth.

Income Statement

WellCell Holdings has demonstrated consistent revenue growth over the years, with a notable increase from 2023 to 2024. The gross profit margin has slightly decreased, indicating potential cost pressures. The net profit margin remains stable, reflecting effective cost management. However, the declining EBIT margin suggests rising operational expenses.

Balance Sheet

The company's debt-to-equity ratio is relatively low, indicating conservative leverage. The equity ratio is strong, showing a solid equity base. However, the return on equity has slightly decreased, suggesting less efficient use of equity capital compared to previous years.

Cash Flow

The cash flow statement reveals a concerning decline in operating cash flow, turning negative in 2024. Free cash flow has also deteriorated significantly, indicating potential liquidity challenges. The operating cash flow to net income ratio is negative, highlighting cash flow issues despite profitability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	262.20M	278.22M	255.96M	226.51M	203.34M	195.57M
Gross Profit	166.02M	56.72M	61.61M	66.70M	87.58M	94.52M
EBITDA	134.65M	25.88M	26.31M	33.23M	32.80M	36.93M
Net Income	17.14M	20.14M	20.40M	24.26M	25.52M	29.66M
Balance Sheet
Total Assets	306.88M	325.32M	183.59M	163.18M	149.86M	126.68M
Cash, Cash Equivalents and Short-Term Investments	68.77M	116.58M	23.81M	42.20M	21.54M	23.13M
Total Debt	34.01M	43.98M	28.14M	30.08M	8.29M	6.86M
Total Liabilities	98.97M	124.95M	98.44M	82.44M	78.78M	61.16M
Stockholders Equity	207.91M	200.37M	85.15M	80.74M	71.09M	65.52M
Cash Flow
Free Cash Flow	-4.68M	-38.60M	5.96M	15.67M	23.00M	12.08M
Operating Cash Flow	4.58M	-15.95M	6.03M	16.96M	25.02M	13.23M
Investing Cash Flow	-19.45M	-20.73M	131.00K	-1.20M	-3.79M	-1.07M
Financing Cash Flow	20.73M	117.90M	-24.55M	4.89M	-22.82M	-12.13M

WellCell Holdings Co., Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2477, the sentiment is Positive. The current price of 10.02 is above the 20-day moving average (MA) of 9.55, above the 50-day MA of 8.39, and above the 200-day MA of 7.85, indicating a bullish trend. The MACD of 0.68 indicates Positive momentum. The RSI at 62.11 is Neutral, neither overbought nor oversold. The STOCH value of 41.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2477.

WellCell Holdings Co., Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
0315	81 Outperform	HK$5.15B	10.77	―	6.84%	0.52%	2.07%
0215	58 Neutral	HK$5.25B	218.00	0.06%	6.87%	6.79%	―
2477	55 Neutral	―	541.62	8.55%	―	5.58%	3.93%
8337	52 Neutral	HK$25.96M	-4.04	-23.29%	―	-35.91%	38.89%
1723	49 Neutral	HK$978.50M	475.56	1.68%	2.34%	-24.89%	-87.87%
Sector *	60 Neutral	$48.67B	4.58	-11.27%	4.14%	2.83%	-41.78%

WellCell Holdings Co., Limited Corporate Events

WellCell Holdings Enhances Fopay Platform with New Business Update

WellCell Holdings Co., Limited announced a business update for its Fopay platform, a one-stop payment solution operated by its subsidiary WellCell NexGen. Fopay enables users to transfer stablecoins and use prepaid VISA cards, generating revenue through service fees and commissions. The platform is managed by experienced personnel and emphasizes legal and regulatory compliance, partnering with licensed custodians and card issuers to ensure seamless and compliant operations.

WellCell Holdings Launches Fopay Stablecoin Payment Platform

WellCell Holdings Co., Limited has announced the launch of ‘Fopay,’ a self-developed global stablecoin currency payment platform. This move marks the company’s entry into the encrypted payments sector, leveraging stablecoins for seamless transactions. The platform offers stablecoin custody and prepaid card payment functions, aligning with global trends towards standardized digital asset frameworks. The launch is expected to open new business opportunities and benefit shareholders.

WellCell Holdings Expands into Fintech and Payment Services

WellCell Holdings Co., Limited has announced plans to diversify its business portfolio by exploring new business segments in payment services and fintech, leveraging blockchain technology. This strategic move aims to maximize shareholder value and capitalize on the rapid growth of e-commerce and mobile payment sectors, particularly in Hong Kong, which offers a robust infrastructure and a digitalized user base. The expansion is expected to facilitate business growth and sustainable development for the company.

WellCell Holdings Announces AGM Results and Board Changes

WellCell Holdings Co., Limited announced the successful passing of all resolutions at its 2024 Annual General Meeting, including the re-election of several directors and the appointment of a new director. The company also confirmed a change in its chairman and adjustments to the composition of its board committees, which may influence its strategic direction and governance.

WellCell Holdings Announces Board Composition and Roles

WellCell Holdings Co., Limited, a company incorporated in the Cayman Islands, has announced the composition of its board of directors and their respective roles and functions. The board comprises executive directors, a non-executive director, and independent non-executive directors, with various members serving on four board committees. This announcement provides clarity on the company’s governance structure, which could impact its strategic decision-making and stakeholder confidence.